Stocks to sell

When I last weighed in on Chesapeake Energy (OTCMKTS:CHKAQ), I said, “Bankruptcy is in the offing, as the energy firm buckles under far too much debt.” That was back in May 2020, as Chesapeake Energy stock traded at $31 after a 200:1 reverse split. Source: IgorGolovniov / Shutterstock.com But that was a no-brainer observation. With high

iBio Pharma (NYSEAMERICAN:IBIO) remains behind in the world’s vaccine quest. And just as quickly as it rose, IBIO stock is quickly fading into irrelevance. Source: Shutterstock The company’s FastPharming platform, using plant-based protein production, is unique and interesting. I can see how theoretically it could be used to quickly mass-produce a novel coronavirus vaccine. But

Berkshire Hathaway’s (NYSE:BRK.A, NYSE:BRK.B) second-quarter 13F report says all you need to know about Occidental Petroleum (NYSE:OXY) and OXY stock. Source: Pavel Kapysh / Shutterstock.com You shouldn’t own it. It’s that simple.  After Warren Buffett threw in the towel on OXY stock, the average investor has no business jumping into this quagmire of a stock.

Even with the novel coronavirus taking a major toll on the economy, some businesses are weathering the financial storm. Costco (NASDAQ:COST) is an excellent example of this, as consumers continue to flock to the discount retailer for essential items. As a result, the Costco stock price has maintained a steady upward trajectory in recent months.

It seems that every week or so, another pharmaceutical company announces a breathtaking, breathless breakthrough on the way to perfecting a vaccine for the novel coronavirus. And those who’ve monitored Inovio (NASDAQ:INO) stock know how crowded the field is: At least 15 companies are vying to cross the finish line first. It’s enough to conjure

Shares of Ford (NYSE:F) are a lot like sugar cookies. They aren’t expensive and hey, it’s a long time until dinner. Meanwhile, there’s little nutritional value and the blast of sugar isn’t healthy. F stock, these days, is more like a cheap cookie without the sweet taste. That may be OK if you’re seeking a

By any conventional measure Amazon (NASDAQ:AMZN) is overvalued. With a market cap of $1.66 trillion, AMZN stock is being valued at over four times its potential 2020 revenue of $400 billion. That’s based on its second quarter sales of $101 billion. Source: Jonathan Weiss / Shutterstock.com It’s not unusual to value a tech company at 10

Children’s entertainment company Genius Brands (NASDAQ:GNUS) went on a wild ride earlier this summer. GNUS stock rallied from less than 50 cents to a peak of more than $10 in share in June. Source: patat / Shutterstock.com At the time, traders rushed to call the company’s new Kartoon Channel app the Netflix (NASDAQ:NFLX) for kids. That comparison

Coca-Cola (NYSE:KO) is the world’s largest soft drink maker and it has one of the most recognizable brands of any company in any industry, but KO stock lacks sizzle and it has for some time. Source: Fotazdymak / Shutterstock.com Undoubtedly, there was a time when Coca-Cola was a cornerstone of many Americans’ portfolios. Should today’s

Readers of mine know that I’m very bullish on clean energy stocks, since I see the world in 2030 as one being populated with electric vehicles, hydrogen fuel cells and hydrogen/wind/solar power.  But one obscure, small clean energy stock which I haven’t rung the bull horn on is FuelCell Energy (NASDAQ:FCEL). That’s because in my

Since the pandemic began, I’ve been bullish on U.S. airline equities, including American Airlines (NASDAQ:AAL), as I predicted that demand for flights in the U.S. this summer would far surpass the Street’s average estimates, but as summer starts to wind down it’s unclear that AAL stock is still a buy. Source: GagliardiPhotography / Shutterstock.com My

The last time I wrote about Ocugen (NASDAQ:OCGN), OCGN stock was up 34% only halfway through the month of January. Since then, a whole bunch of stuff happened, some of it good, some of it bad, none of it worthy of you betting the farm on the clinical-stage biopharma company. Source: luchschenF / Shutterstock.com Here’s

There are always investors looking to make a contrarian play. Maybe that’s why you’re considering Hertz (NYSE:HTZ). Even though Hertz stock is in bankruptcy, you’re thinking you see something that other investors haven’t identified. Source: aureliefrance / Shutterstock.com Stop. Just stop it, at least when it comes to Hertz stock. Because the rental car company

Overstock.com (NASDAQ:OSTK) stock is proof of why investors shouldn’t be scared to chase rallies, so long as those rallies are well-founded and the valuation leaves room for further upside. Back in early May, OSTK stock flew on my screen as one of the hottest e-commerce stocks in the market. Source: Burdun Iliya / Shutterstock.com At

This year changed the travel industry in more ways than one. Cruise operators like Carnival (NYSE:CCL) have seen their operations come to almost a complete halt. As a result, CCL stock is down over 70%. In early January, Carnival prided itself on being the world’s largest cruise operator. The group owns major cruise brands including

Ford (NYSE:F) surprised Wall Street earlier this month with second-quarter results that were “way, way, way better than feared.” Ford stock jumped 4.3% on the news as investors rushed back in. According to Robintrack, Ford is now the most owned company by Robinhood investors. Source: Philip Lange / Shutterstock.com But there’s a problem: Ford isn’t

I have been consistently negative on iBio (NASDAQ:IBIO) as a potential vaccine play for most investors. You might be better off avoiding IBIO stock to find a successful novel coronavirus vaccine play. One of the reasons is that the company is far behind its competitors in their vaccine trials. Source: Shutterstock Despite the progress report

The electric car industry is booming, and industry stalwarts like Tesla (NASDAQ:TSLA) are reaping the benefits. Meanwhile, gimmicky companies like Electrameccanica Vehicles (NASDAQ:SOLO) have only enjoyed a fraction of the success. While EV stocks like Tesla and Nikola (NASDAQ:NKLA) have powered higher this year, SOLO stock is far less glamorous. Source: buffaloboy / Shutterstock.com The

Home Depot (NYSE:HD) stock failed to rally in mid-August  despite reporting second quarter numbers that simply blew estimates out of the water. Source: Jonathan Weiss / Shutterstock.com Normally when a red-hot stock fails to rally after super-strong numbers, that’s a sign of valuation friction and rally exhaustion. And that’s exactly what we’re seeing with HD

Shares of Ocugen (NASDAQ:OCGN) have climbed nearly 180% in the last month. However, OCGN stock is still trading at just 57 cents a share. That’s the life of a penny stock. And that’s the only story you need to know about Ocugen. Source: Shutterstock The reason the stock is rising is genuinely good news. The